U.S. Markets closed
  • S&P 500

    3,629.65
    -5.76 (-0.16%)
     
  • Dow 30

    29,872.47
    -173.77 (-0.58%)
     
  • Nasdaq

    12,094.40
    +57.62 (+0.48%)
     
  • Russell 2000

    1,845.02
    -8.51 (-0.46%)
     
  • Crude Oil

    44.96
    -0.75 (-1.64%)
     
  • Gold

    1,814.10
    +2.90 (+0.16%)
     
  • Silver

    23.44
    -0.01 (-0.03%)
     
  • EUR/USD

    1.1912
    -0.0007 (-0.0596%)
     
  • 10-Yr Bond

    0.8780
    -0.0040 (-0.45%)
     
  • Vix

    21.25
    -0.39 (-1.80%)
     
  • GBP/USD

    1.3351
    -0.0032 (-0.2390%)
     
  • USD/JPY

    104.2480
    -0.1920 (-0.1838%)
     
  • BTC-USD

    16,720.78
    -1,258.39 (-7.00%)
     
  • CMC Crypto 200

    325.59
    -44.93 (-12.13%)
     
  • FTSE 100

    6,362.93
    -28.16 (-0.44%)
     
  • Nikkei 225

    26,537.31
    +240.45 (+0.91%)
     

Intra-cellular Therapies Inc (ITCI) SVP of Finance CFO Lawrence J. Hineline Sold $712,344 of Shares

GuruFocus.com
·1 min read

- By insider

SVP of Finance CFO of Intra-cellular Therapies Inc (30-Year Financial, Insider Trades) Lawrence J. Hineline (insider trades) sold 28,034 shares of ITCI on 11/11/2020 at an average price of $25.41 a share. The total sale was $712,344.


Intra-Cellular Therapies Inc is a biopharmaceutical company. It is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders. Intra-Cellular Therapies Inc has a market cap of $2.15 billion; its shares were traded at around $26.77 with and P/S ratio of 174.97. GuruFocus has detected 4 severe warning signs with Intra-Cellular Therapies Inc. .

CEO Recent Trades:

  • Chairman, President & CEO Sharon Mates sold 50,000 shares of ITCI stock on 11/10/2020 at the average price of $26.34. The price of the stock has increased by 1.63% since.

  • Chairman, President & CEO Sharon Mates sold 50,000 shares of ITCI stock on 11/04/2020 at the average price of $25. The price of the stock has increased by 7.08% since.

CFO Recent Trades:

  • SVP of Finance CFO Lawrence J. Hineline sold 28,034 shares of ITCI stock on 11/11/2020 at the average price of $25.41. The price of the stock has increased by 5.35% since.

Directors and Officers Recent Trades:

  • EVP, Chief Commercial Officer Mark Neumann sold 6,792 shares of ITCI stock on 10/16/2020 at the average price of $26.8. The price of the stock has decreased by 0.11% since.

For the complete insider trading history of ITCI, click here

.This article first appeared on GuruFocus.